SCHEMBL19081899

SCHEMBL19081899

c1ccc(-c2c3ccccc3c(-c3ccc(-c4c5sc6ccc7ccccc7c6c5cc5oc6ccccc6c45)cc3)c3ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ABCG2 Q9UNQ0 6/20 0.37
PAX8 Q06710 2/20 0.37
CYP1A1 P04798 2/20 0.37
CYP1A2 P05177 1/20 0.37
FYN P06241 1/20 0.37
MAPK3 P27361 1/20 0.37
AHR P35869 1/20 0.37
NPC1 O15118 2/20 0.32
RAB9A P51151 1/20 0.32
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
CYP1B1 Q16678 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
KMT2A Q03164 2/20 0.31
MAPK1 P28482 1/20 0.31
KDM4E B2RXH2 3/20 0.31
PLA2G2A P14555 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081935 0.91 TDP1 (0.34) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL19081988 0.91 TDP1 (0.34) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL19081863 0.87 ABCG2 (0.34) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL19081791 0.83 TDP1 (0.36) TDP1L3MBTL1AHRNQO1NQO2
SCHEMBL19081764 0.82 ABCG2 (0.40) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL19076872 0.81 PLA2G2A (0.34) ABCG2PAX8CYP1A1CYP1A2FYN
SCHEMBL19081888 0.81 ABCG2 (0.40) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL19081821 0.81 ABCG2 (0.40) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL19076813 0.81 ESR1 (0.33) TDP1L3MBTL1ABCG2PAX8CYP1A1
SCHEMBL19082078 0.80 TDP1 (0.30) TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ABCG2 4823/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ABCG2 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.